218 related articles for article (PubMed ID: 30980769)
1. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
4. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram prediction model for malignant transformation of oral potentially malignant disorders.
Cai X; Zhang J; Han Y; Tang Q; Zhang H; Li T
Oral Oncol; 2021 Dec; 123():105619. PubMed ID: 34818615
[TBL] [Abstract][Full Text] [Related]
6. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
7. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
8. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
[TBL] [Abstract][Full Text] [Related]
11. Oral leukoplakia: A clinicopathological study and malignant transformation.
Tovaru S; Costache M; Perlea P; Caramida M; Totan C; Warnakulasuriya S; Parlatescu I
Oral Dis; 2023 May; 29(4):1454-1463. PubMed ID: 34982498
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
13. The"Newcastle Nomogram"-Statistical modelling predicts malignant transformation in potentially malignant disorders.
Goodson ML; Smith DR; Thomson PJ
J Oral Pathol Med; 2019 Sep; 48(8):662-668. PubMed ID: 31125457
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
16. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
[TBL] [Abstract][Full Text] [Related]
19. Oral cancer development in patients with leukoplakia--clinicopathological factors affecting outcome.
Liu W; Shi LJ; Wu L; Feng JQ; Yang X; Li J; Zhou ZT; Zhang CP
PLoS One; 2012; 7(4):e34773. PubMed ID: 22514665
[TBL] [Abstract][Full Text] [Related]
20. [The expression and clinical significance of Bmi-1 gene in oral leukoplakia with different prognosis].
Wu XB; Wang RY; Gong SR; Zhu J; Zhu S
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(11):787-794. PubMed ID: 35325958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
